Ombitasvir/Paritaprevir/Ritonavir + Ribavirin
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Ombitasvir/Paritaprevir/Ritonavir + Ribavirin, covering 2020-01-10 to 2020-01-10. Get the full timeline:
Most recent: Clinical Trial Update: Ombitasvir/ Paritaprevir / Ritonavir Plus Ribavirin in Management HCV and End-stage Kidney Disease [Phase 4]